Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 2007, p. 3449-3452, Vol. 45, No. 10
0095-1137/07/$08.00+0 doi:10.1128/JCM.00765-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |

*
Catherine A. Sheils,2,
Barbara A. Brown-Elliott,3,
Nadege Charles,1
Andrew A. Colin,4
Mary J. Gant,6
John Goodill,6
Diane Hindman,5
Sean R. Toney,1
Richard J. Wallace Jr.,3 and
Mitchell A. Yakrus1
Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia,1 Harvard Medical School, Boston, Massachusetts,2 Mycobacteria/Nocardia Laboratory, Biomedical Research Section-2, The University of Texas Health Center, Tyler, Texas,3 Division of Pediatric Pulmonology, Miller School of Medicine, University of Miami, Miami, Florida,4 Delaware Public Health Laboratory, Smyrna, Delaware,5 Christiana Care Health Services, Adult Cystic Fibrosis Program, Newark, Delaware6
Received 10 April 2007/ Returned for modification 22 June 2007/ Accepted 24 July 2007
We report three cases of the new genus Segniliparus isolated from patients with cystic fibrosis. All isolates were unambiguously identified by 16S rRNA gene sequencing as Segniliparus rugosus (GenBank accession no. AY 60892). Drug susceptibility results that may enhance treatment for cystic fibrosis patients with this opportunistic pathogen are presented.
Published ahead of print on 1 August 2007.
These authors contributed equally to this work.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»